The implantation of a total artificial heart system is a potential treatment option for patients with heart failure who need support while on the heart transplant waiting list and for those who do not qualify for a transplant.  Learn more about progress toward new solutions for these patients.

BiVacor wins FDA IDE for first-in-human artificial heart study
NOVEMBER 29, 2023 BY SEAN WHOOLEY

---

Related Stories

US FDA Grants the BiVACOR Total Artificial Heart IDE Approval for First-in-Human Early Feasibility Study

Houston medical device company with long-lasting artificial heart reaches FDA milestone

Houston company behind game changing artificial heart gets FDA green light